pMSCV-MAVS(KaganE17) Citations (1)

Originally described in: A Bicistronic MAVS Transcript Highlights a Class of Truncated Variants in Antiviral Immunity.
Brubaker SW, Gauthier AE, Mills EW, Ingolia NT, Kagan JC Cell. 2014 Feb 13;156(4):800-11. doi: 10.1016/j.cell.2014.01.021. PubMed Journal

---

Articles Citing pMSCV-MAVS(KaganE17)

Articles
Rotavirus VP3 targets MAVS for degradation to inhibit type III interferon expression in intestinal epithelial cells. Ding S, Zhu S, Ren L, Feng N, Song Y, Ge X, Li B, Flavell RA, Greenberg HB. Elife. 2018 Nov 21;7. pii: 39494. doi: 10.7554/eLife.39494. PubMed

If you have published an article using this material, please email us at to have your article added to this page.